article

1. "First, Trust Needs to Develop": Hematologists' Perspectives on Factors Influencing Black Persons' Participation in Clinical Trials..  Journal of racial and ethnic health disparities.  12:4111-4124. 2024
2. A scoping review of racial, ethnic, socioeconomic, and geographic disparities in the outcomes of older adults with cancer..  Journal of the American Geriatrics Society.  72:1867-1900. 2024
3. Systematic Review of Interventions Addressing Racial and Ethnic Disparities in Cancer Care and Health Outcomes..  Journal of clinical oncology : official journal of the American Society of Clinical Oncology.  42:1563-1574. 2024
4. Opportunities, challenges, and future directions for simulation modeling the effects of structural racism on cancer mortality in the United States: a scoping review..  Journal of the National Cancer Institute. Monographs.  2023:231-245. 2023
5. "Just give it to us straight!": a qualitative analysis of midwestern rural lung cancer survivors and caregivers about survivorship care experiences..  Journal of cancer survivorship : research and practice.  19:21-34. 2023
6. Chimeric Antigen Receptor T-Cell and Bispecific Antibody Therapy in Multiple Myeloma: Moving Into the Future..  Journal of clinical oncology : official journal of the American Society of Clinical Oncology.  41:4416-4429. 2023
7. Global disparities in patients with multiple myeloma: a rapid evidence assessment..  Blood cancer journal.  13:-. 2023
8. "A lot to manage and still have some kind of a life": How multiple myeloma impacts the function and quality-of-life of Black-White patient-caregiver dyads..  Journal of the American Geriatrics Society.  71:3208-3220. 2023
9. Partnering With All Patients: Ensuring Shared Decision Making and Evidence-Based Management for Underrepresented Groups With Multiple Myeloma..  American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.  -. 2023
10. A real-world data analysis of predictors of early mortality after a diagnosis of multiple myeloma..  Cancer.  129:2023-2034. 2023
11. The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review..  Blood cancer journal.  13:-. 2023
12. Cross-Sectional Analysis of Clinical Trial Availability and North Carolina Neighborhood Social Vulnerability..  JCO oncology practice.  19:-. 2022
13. Longitudinal Analysis of Patient-Reported Cognitive Function in Multiple Myeloma..  Clinical lymphoma, myeloma & leukemia.  22:920-927. 2022
14. Physical Function, Psychosocial Status, and Symptom Burden Among Adults with Plasma Cell Disorders and Associations with Quality of Life..  The oncologist.  27:694-702. 2022
15. Use of geriatric assessment in cancer clinical trials: A systematic review..  Journal of geriatric oncology.  13:907-913. 2022
16. Prevalence and clinical correlates of cognitive impairment in adults with plasma cell disorders..  Journal of geriatric oncology.  13:987-996. 2022
17. Clinical Presentation, Risk Factors, and Outcomes of Immune Effector Cell-Associated Neurotoxicity Syndrome Following Chimeric Antigen Receptor T Cell Therapy: A Systematic Review..  Transplantation and cellular therapy.  28:294-302. 2022
18. What Is Multiple Myeloma?.  JAMA.  327:-. 2022
19. Treatment of older adult or frail patients with multiple myeloma..  Hematology. American Society of Hematology. Education Program.  2021:46-54. 2021
20. SOHO State of the Art Updates and Next Questions: Treatment of Older, Vulnerable Adults with Multiple Myeloma..  Clinical lymphoma, myeloma & leukemia.  22:279-286. 2021
21. Geriatric-assessment-identified functional deficits among adults with multiple myeloma with normal performance status..  Journal of geriatric oncology.  13:182-189. 2021
22. Transplant-ineligible newly diagnosed multiple myeloma: Current and future approaches to clinical care: A Young International Society of Geriatric Oncology Review Paper..  Journal of geriatric oncology.  12:499-507. 2020
23. Management of Frail Older Adults with Newly Diagnosed Multiple Myeloma - Moving Toward a Personalized Approach..  Clinical lymphoma, myeloma & leukemia.  20 Suppl 1:S76-S80. 2020
24. Caring for older adults with multiple myeloma during the COVID-19 Pandemic: Perspective from the International Forum for Optimizing Care of Older Adults with Myeloma..  Journal of geriatric oncology.  11:764-768. 2020
25. Geriatric hematology research at the 2019 American Society of Hematology annual meeting: Young International Society of geriatric oncology perspective paper..  Journal of geriatric oncology.  11:735-739. 2020
26. Simplified frailty assessment tools: are we really capturing frailty or something else?.  Leukemia.  34:1967-1969. 2020
27. Perspectives on geriatric oncology research presented at the 2019 International Society of Geriatric Oncology Annual Meeting: Young International Society of Geriatric Oncology report..  Journal of geriatric oncology.  11:549-552. 2020
28. Burkitt lymphoma of the maxilla in a HIV positive male - Presentation and review of diagnostic laboratory tests..  Oral and maxillofacial surgery cases.  5. 2019
29. Quality of direct oral anticoagulant prescribing in elderly patients with non-valvular atrial fibrillation: results from a large urban health system..  Journal of thrombosis and thrombolysis.  46:1-6. 2018
30. Autologous Stem-Cell Transplantation Without Hematopoietic Support for the Treatment of Hematologic Malignancies in Jehovah's Witnesses..  Journal of clinical oncology : official journal of the American Society of Clinical Oncology.  33:1674-9. 2015
31. Superior vena cava syndrome as an initial presentation of low-grade follicular lymphoma..  The Journal of community and supportive oncology.  12:415-7. 2014
32. A severe pneumonia due to methicillin resistant staphylococcus aureus clone USA 300: implications of vertical transmission..  The West Indian medical journal.  61:145-7. 2012